TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IMTX

Immatics NV

Healthcare · Biotechnology

8.50$ +1.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Immatics NV (IMTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 48 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Income Statement IMTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
3.8 18 31 35 173 54 156 48
34 40 67 88 107 119 148 –
-30 -22 -36 35 173 54 156 48
34 40 67 88 107 119 148 184
7.7 12 34 34 36 38 46 51
38 51 34 121 143 156 194 230
-34 -33 -70 -86 30 -102 -39 -182
0.0 0.2 0.3 0.6 1.0 0.8 0.9 0.9
-32 -32 -212 -93 42 -97 21 -198
-3.0 -0.7 -0.3 1.7 14 -2.3 6.1 -2.0
-31 -32 -211 -93 28 -95 15 -196
-32 -28 -67 -88 50 -89 34 -185

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?